Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hasan Bsc Shahriyer Tonmoy has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Global epidemiology of hepatitis B virus infection in dialysis patients: a systematic review and meta-analysis of prevalence, immunity, risk factors, and beyond

    by Alif Hasan Pranto, Ehsan Suez, Ekhtiar Uddin, Hasan Shahriyer Tonmoy, M. M. Rubaiyat Muntasir Meem, Fahim Montasir, Farzana Nourin, Farhana Ahmed, Shifaty Nur Abir, Dewan Zubaer Islam, et al.

    Hepatitis B infection is a global threat caused by the Hepatitis B virus (HBV), which can be transmitted through blood transfusions. Again, dialysis is a mechanical process that is used to filter the blood of patients with chronic kidney disease (CKD). In this study, we aimed to evaluate the worldwide prevalence of HBV infection using primary published data on hepatitis B virus surface antigen (HBsAg) and HBV-DNA prevalence among dialysis patients. To obtain the data, we searched three different online databases, and from 479 studies, 79 articles were selected for this study. Besides prevalence analysis, study outliers, quality, and characteristics were identified as well. We found the pooled prevalence of HBsAg and HBV-DNA to be 7.0% (95%CI: 6.1-8.0) and 1.5% (95%CI: 1.0-1.9), respectively, although, excluding the outliers, the prevalence of HBsAg became 6.3%, but HBV-DNA remained the same. Besides, we determined that 49.2% (95%CI: 30.2-68.1) of dialysis patients took the HBV vaccine, and 40.0% (95%CI: 31.1-48.8) of patients developed natural immunity (anti-HBV antibody). Among continent-based analyses, Australia was determined to have the highest prevalence of HBsAg (8.7%), and Asia and Africa were found to have the same and highest prevalence of HBV-DNA (4.1%). Among risk factors, blood transfusion was the highest, followed by duration of dialysis, HCV/other infections, renal diseases, and so on. This study indicates the importance of careful and contamination risk-free dialysis among patients, vaccination, and early diagnosis of HBV to avoid and prevent the risk of HBV infection.


  • Open Access

    Prevalence of HIV/AIDS among pregnant women in North American region: A systematic review and meta-analysis

    by Nosheena Akhter Mbbs Shabbir, Sara Bashir Mbbs Kant, Kainat Mbbs Rashid, Uzma Mbbs Hafeez, Aiza Ali Mbbs Akbar, Syeda Wajiha Mbbs Batool, Alif Hasan Bsc Pranto, Jemema Zaman, Hasan Bsc Shahriyer Tonmoy, Rashedul Islam, et al.

    Background: As a major maternal health concern, the prevalence of human immunodeficiency virus (HIV) among pregnant women was previously investigated in European, African, and Latin American regions other than the North American region. This study analyzed the prevalence of HIV among pregnant women in the North American region including 3 major countries: the USA, Canada, and Mexico. Methods: Relevant studies were screened from 3 online databases: Google Scholar, PubMed, and ScienceDirect using specific search keywords. Ultimately, 10 studies of the North American region were included with a total of 339,831 pregnant women residing in the USA, Canada, and Mexico. Results: The overall pooled prevalence was 0.6% (95% confidence interval [CI]: 0.4–0.8) with a high degree of heterogeneity (I 2 = 97%). Pooled prevalence rates of HIV among pregnant women in Canada, Mexico, and the USA were 0.3% (95% CI: 0.1–0.5), 0.5% (95% CI: 0.2–0.8), and 2.3% (95% CI: 0.0–5.7), respectively with high degrees of heterogeneity. Conclusion: The overall prevalence rate of HIV among pregnant women in the USA, Canada, and Mexico was minimal as compared with the countries of Eastern Europe, sub-Saharan Africa, or Latin America. Awareness, adequate testing and healthcare facilities, better socioeconomic, and geopolitical conditions might be crucial to lowering the prevalence of HIV among pregnant women.